ASX-Dividend-Report-Banner

India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad

June 10, 2024 05:40 PM AEST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad
Image source: Kalkine Media

HYDERABAD, India, June 10, 2024 /PRNewswire/ -- The Bio Regenerative Precision Medicine Seminar, held from May 18-20, 2024, at Le Méridien in Hyderabad, was a watershed moment in India's cell treatment journey.

Prof. Dr Mike Chan, Chairman and Founder of European Wellness Biomedical Group (EWBG), chaired the event, which highlighted advances in precision medicine as well as the transformational potential of individualised therapies, making the first EWBG comeback into India in a gigantic leap after its initial visit back in 2006. 

This comeback is primarily focused on education, research, and biopharmaceutical production, cooperating with the research institutions in India such as the Council of Scientific & Industrial Research- Centre for Cellular & Molecular Biology (CSIR-CCM)'s Atal Incubation Centre (AIC), the Centre for Cellular and Molecular Platforms (C-CAMP) in Bengaluru, International Institute of Information Technology (IIIT) Hyderabad, and others.

The introduction of the LOOP Mobile Application, which was developed to link Indian doctors, patients, and scientists, improved cooperation and transparency in cell therapy research.

Esteemed specialists, including Prof. Dr Ravi Tej Allam, CEO of EWBG Bharat, and experts Prof. Dr Dmytro Klokol, Prof. Dr Olha Nishkumai, Prof. Dr Margaryta Iemelianova, and Prof. Dr Simon Yefimov, discussed bio regenerative therapy for heart disease, liver illness, renal failure, severe burns, and arthritis.

"Cell therapy is a God-sent to humanity where there is regeneration of organs with an advanced medical technique," stated Prof. Dr Mike Chan.

On the same note, EWBG is also delighted to announce the formation of an Indian branch for the International Association of Stem Cell Therapy, Europe (IACT), the International Association for Stem Cell Transplantation, USA (IASCT) and the European Society for Preventive, Regenerative, and Anti-Aging Medicine (ESAAM).

EWBG intends to open a production facility in India for cell therapy diagnostics, making treatments affordable and accessible, particularly to impoverished areas.

EWBG's Corporate Social Responsibility (CSR) initiatives include medical help for frontline Indian soldiers, athletes, and support for youngsters with special needs.

Mr. Pavan Kalyan, President of the Janasena Party, and his General Secretary, Mr. Bolisetty Satyanarayana, who donated land in Andhra Pradesh for European Wellness's production plant, were among those honoured, as was Mr. A.M. Rathnam, a well-known film producer, lyricist, screenwriter, and director known for his works in Telugu and Tamil cinema.

This event was a groundbreaking moment in bio regenerative medicine, paving the path for worldwide health collaboration.

Media Contact: 

EW Group Media Team, [email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.